CN Patent

CN107522716B — 丙型肝炎病毒抑制剂及应用

Assigned to Zhejiang Palo Alto Pharmaceuticals Inc · Expires 2021-02-02 · 5y expired

What this patent protects

本发明涉及一种丙型肝炎病毒抑制剂及应用。具体地，本发明公开了可用作丙型肝炎病毒抑制剂的式(I)所示的化合物，或其光学异构体、药学上可接受的盐、水合物或溶剂化物，其可用于治疗丙型肝炎病毒(HCV)感染或丙型肝炎疾病，也可用作丙型肝炎病毒非结构5A(NS5A)蛋白抑制剂。

USPTO Abstract

本发明涉及一种丙型肝炎病毒抑制剂及应用。具体地，本发明公开了可用作丙型肝炎病毒抑制剂的式(I)所示的化合物，或其光学异构体、药学上可接受的盐、水合物或溶剂化物，其可用于治疗丙型肝炎病毒(HCV)感染或丙型肝炎疾病，也可用作丙型肝炎病毒非结构5A(NS5A)蛋白抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN107522716B
Jurisdiction
CN
Classification
—
Expires
2021-02-02
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Palo Alto Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.